Who
Christopher Galletta
Officer
Company insider
Files Form 4 as: Officer, Trevi Therapeutics; Corporate Controller, TransAct Technologies.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $25K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 27 May 2010
- Last trade
- 19 Feb 2026
- Last filed
- 20 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Feb 2026filed 20 Feb 2026 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 2 Dec 2025filed 3 Dec 2025 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,225 at $0.00 | filing |
| 2 Dec 2025filed 3 Dec 2025 | TRVI Trevi TherapeuticsBiotechnology | SEC FORM 4 Code M | $2,1554,225 at $0.51 | filing |
| 31 May 2025filed 3 Jun 2025 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,550 at $0.00 | filing |
| 10 Mar 2025filed 12 Mar 2025 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,560 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,000 at $0.00 | filing |
| 13 Dec 2024filed 17 Dec 2024 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 13 Dec 2024filed 17 Dec 2024 | TRVI Trevi TherapeuticsBiotechnology | SEC FORM 4 Code M | $7,65015,000 at $0.51 | filing |
| 15 Feb 2024filed 16 Feb 2024 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,500 at $0.00 | filing |
| 16 Feb 2023filed 16 Feb 2023 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 11 Feb 2022filed 15 Feb 2022 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 13 Apr 2021filed 15 Apr 2021 | TRVI Trevi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 2 Jan 2012filed 4 Jan 2012 | TACT TransAct Technologiesoption or derivative · Hardware, Devices & Storage | SEC FORM 4 Code M | $1,090500 at $2.18 | filing |
| 2 Jan 2012filed 4 Jan 2012 | TACT TransAct TechnologiesHardware, Devices & Storage | SEC FORM 4 Code M | $1,090500 at $2.18 | filing |
| 11 May 2011filed 12 May 2011 | TACT TransAct Technologiesoption or derivative · Hardware, Devices & Storage | SEC FORM 4 Code M | $2,620500 at $5.24 | filing |
| 11 May 2011filed 12 May 2011 | TACT TransAct Technologiesoption or derivative · Hardware, Devices & Storage | SEC FORM 4 Code M | $218100 at $2.18 | filing |
| 11 May 2011filed 12 May 2011 | TACT TransAct TechnologiesHardware, Devices & Storage | SEC FORM 4 Code M | $2,620500 at $5.24 | filing |
| 11 May 2011filed 12 May 2011 | TACT TransAct TechnologiesHardware, Devices & Storage | SEC FORM 4 Code M | $218100 at $2.18 | filing |
| 11 May 2011filed 12 May 2011 | TACT TransAct TechnologiesHardware, Devices & Storage | SEC FORM 4 Sold | $7,458600 at $12.43 | filing |
News
Financial Analysis: TransAct Technologies (NASDAQ:TACT) versus Western Digital (NASDAQ:WDC)TACT · tickerreport.com · 15 Oct 2026TransAct Technologies Incorporated (NASDAQ:TACT) Sees Large Drop in Short InterestTACT · tickerreport.com · 14 Oct 2026TransAct Technologies (NASDAQ:TACT) Shares Break Above Two Hundred Day Moving Average – Here's WhyTACT · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Christopher Galletta; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.